Risedronate sodium or risedronic acid
- Level
- Commodity
- Parent
- 51182400
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51182417This classification denotes a bone resorption inhibitor and biphosphonate with the molecular formula C7H11NO7P2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KM2Z91756Z, chemically known as phosphonic acid, (1-hydroxy-2-(3-pyridinyl)ethylidene)bis- but generally known as risedronic acid, which bears US NIH Compound Identifier 5245. European Medicines Agency schedules Risedronic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10330MIG. The term RISEDRONIC ACID is an International Non-Proprietary Name. World Health Organization schedules risedronic acid in its Anatomical Therapeutic Chemical (ATC) Classification. Risedronate sodium or risedronic acid bears US NLM identifiers UMLS ID C0140610 and NCI Concept Code C66517. SMILES: P(=O)(O)(O)C(P(=O)(O)O)(O)CC1CCCNC1.
Same parent
Under 51182400 · 28Activities that produce or sell this
KBLI · 8Inherited from family 51180000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.